global
pandem
emerg
viru
consid
lack
effect
pharmaceut
treatment
urgent
need
identifi
safe
effect
drug
potenti
adjuv
therapi
regard
bioactiv
lipid
array
known
healthpromot
properti
suggest
effect
agent
allevi
acut
respiratori
stress
induc
viru
bioactiv
lipid
amid
oleoylethanolamid
oea
due
sever
distinct
homeostat
properti
includ
antiinflammatori
activ
modul
immun
respons
antioxid
effect
consid
novel
potenti
pharmacolog
altern
manag
novel
coronaviru
led
econom
disrupt
global
health
concern
due
sustain
humantohuman
transmiss
rapid
spread
april
sever
acut
respiratori
syndrom
affect
total
confirm
case
death
countri
territori
acut
respiratori
distress
syndrom
ard
result
multipl
organ
failur
sepsi
remain
common
caus
death
patient
older
adult
subject
underli
chronic
ill
includ
cancer
hypertens
diabet
serious
affect
group
current
known
treatment
infect
investig
mani
countri
around
world
undertaken
sever
clinic
trial
solv
problem
highli
transmitt
pathogen
viral
belong
subfamili
orthocoronavirina
famili
coronavirida
order
nidoviral
subfamili
coronavirus
famili
includ
alpha
beta
gamma
delta
coronaviru
coronavirus
initi
thought
infect
anim
evid
last
decad
indic
diseas
capabl
membran
rna
sequenc
approxim
base
length
analysi
genom
sequenc
data
reveal
approxim
similar
sarscov
nucleotid
sequenc
interestingli
new
evid
suggest
rbd
well
suit
bind
human
angiotensinconvert
enzym
receptor
express
membran
variou
cell
bodi
type
ii
alveolar
epitheli
cell
lung
fact
bind
sarscov
receptor
disrupt
function
intestin
kidney
blood
vessel
main
cell
express
fact
may
explain
patient
experi
gastrointestin
symptom
viru
bind
hostcel
receptor
via
particular
surfac
glycoprotein
call
spike
peplom
enter
host
cell
suppos
entri
viru
human
cell
increas
inflammatori
activ
variou
mechan
consequ
releas
proinflammatori
cytokin
caus
seriou
damag
special
respiratori
tract
theoret
assum
decreas
activ
cell
membran
may
reduc
abil
penetr
cell
along
endem
human
coronavirus
seem
becom
fifth
endem
coronaviru
human
popul
nowaday
discov
therapeut
option
current
avail
agent
appear
essenti
treatment
prophylaxi
pandem
manuscript
aim
introduc
oleoylethanolamid
oea
bioactiv
lipid
mediat
novel
potenti
pharmacolog
altern
manag
bioactiv
lipid
amid
oea
synthes
gastrointestin
tract
relat
sever
distinct
homeostat
properti
includ
antiinflammatori
activ
immun
respons
stimul
lipolysi
fatti
acid
oxid
oea
member
nacylethanolamin
nae
famili
deriv
monounsatur
fatti
acid
oleic
acid
previou
studi
indic
downregul
oea
level
aris
situat
exposur
stress
contribut
increas
inflammatori
marker
nae
catabol
current
epidemiolog
studi
inflammatoryrel
diseas
oea
consid
endocannabinoidlik
lipid
interact
peroxisom
proliferatoractiv
mediat
antiinflammatori
process
gener
accept
endocannabinoid
system
ec
consist
membran
cannabinoid
receptor
cannabinoid
receptor
type
type
endogen
ligand
endcannabinoid
enzym
respons
synthesi
degrad
ligand
collabor
ec
manag
elimin
infecti
agent
virus
bacteria
protozoa
indic
previous
scientif
research
recent
show
activ
ec
reliev
pain
reduc
inflamm
lung
base
evid
endogen
exogen
cannabinoid
consid
therapeut
potenti
agent
respiratori
pathogen
clearanc
base
previou
studi
angiotensin
receptor
inhibit
sever
unsatur
fatti
acid
metabolit
oleic
acid
emerg
evid
suggest
fatti
acid
decreas
affin
angiotensin
receptor
recent
evid
also
indic
unsatur
fatti
acid
serv
endogen
antivir
compound
defici
make
human
suscept
certain
viral
infect
includ
sar
mer
view
fact
infect
lead
increas
releas
proinflammatori
cytokin
includ
patient
via
bind
toll
like
receptor
tlr
assum
oea
inhibit
pathway
antiinflammatori
properti
fact
oea
bind
high
affin
receptor
initi
cascad
event
eventu
attenu
inflammatori
respons
tlr
import
compon
innat
immun
system
distinct
class
patternrecognit
receptor
prr
local
cell
surfac
intracellular
compart
endolysosom
endoplasm
reticulum
endosom
lysosom
detect
viral
danger
signal
extracellular
milieu
endosom
leucin
rich
repeatcontain
tran
membran
protein
structur
initi
downstream
signal
culmin
activ
transcript
nuclear
factor
kappa
b
lead
express
inflammatori
cytokin
adhes
molecul
chemokin
peroxisom
proliferatoractiv
receptor
ppar
class
transcript
factor
involv
modul
inflammatori
pathway
nuclear
receptor
protein
consist
three
subtyp
includ
ppar
allevi
express
inflammatori
mediat
via
induc
main
inhibitor
signal
pathway
previous
indic
activ
tlr
pathway
attenu
express
level
ppar
intensifi
express
level
proinflammatori
cytokin
tumor
nex
crosi
interestingli
oea
may
modul
crosstalk
tlr
regul
inflammatori
respons
word
oea
may
benefici
synergist
effect
infect
oea
high
affin
endogen
ligand
bind
receptor
increas
express
level
antiinflammatori
cytokin
addit
attenu
inflammatori
respons
decreas
express
interf
signal
cascad
recent
clinic
trial
oea
supplement
could
decreas
inflamm
obes
patient
via
reduc
serum
concentr
inflammatori
marker
includ
whole
result
found
previou
studi
demonstr
activ
oea
prevent
express
gene
code
sever
inflammatori
cytokin
well
establish
oea
also
significantli
reduc
lipopolysaccharideinduc
oxidativenitros
stress
prevent
endotheli
cell
damag
increas
activ
antioxid
enzym
benefici
effect
oea
justifi
suggest
excess
inflamm
oxid
increas
immun
respons
main
contributor
patholog
oea
antioxid
antiinflammatori
effect
may
effect
attenu
inflamm
oxid
coronaviru
infect
subject
utmost
concern
oea
supplement
patient
safeti
previou
clinic
trial
dose
mgd
oea
oral
intak
particip
exhibit
satisfactori
safeti
compar
placebo
also
even
oea
given
human
dose
mgd
month
side
effect
report
base
avail
evid
exogen
administr
oea
appear
homeostat
signal
counter
infect
allevi
patient
inflammatori
statu
present
decid
conduct
clinic
trial
patient
iran
evalu
hypothesi
hope
result
trial
provid
new
insight
research
tackl
viru
potenti
conflict
interest
disclos
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
